Ausgabe 6/2016
Inhalt (18 Artikel)
Improving Prognostic Modeling in Myelodysplastic Syndromes
Aziz Nazha, Mikkael A. Sekeres
Assessing Quality of Care for the Myelodysplastic Syndromes
Zachary A. K. Frosch, Gregory A. Abel
Targeting Splicing in the Treatment of Myelodysplastic Syndromes and Other Myeloid Neoplasms
Charlotte K. Brierley, David P. Steensma
Activin Receptor II Ligand Traps and Their Therapeutic Potential in Myelodysplastic Syndromes with Ring Sideroblasts
Anna Mies, Olivier Hermine, Uwe Platzbecker
An Exercise in Extrapolation: Clinical Management of Atypical CML, MDS/MPN-Unclassifiable, and MDS/MPN-RS-T
Chetasi Talati, Eric Padron
Palliative and End-of-Life Care in Myelodysplastic Syndromes
Myles Nickolich, Areej El-Jawahri, Thomas W. LeBlanc
Molecular Testing in Patients with Suspected Myelodysplastic Syndromes
Tamara K. Moyo, Michael R. Savona
Social Media and the Adolescent and Young Adult (AYA) Patient with Cancer
Miguel-Angel Perales, Emily K. Drake, Naveen Pemmaraju, William A. Wood
Social Media and Myeloproliferative Neoplasms (MPN): Analysis of Advanced Metrics From the First Year of a New Twitter Community: #MPNSM
Naveen Pemmaraju, Audun Utengen, Vikas Gupta, Jean-Jacques Kiladjian, Ruben Mesa, Michael A. Thompson
Social Media and Internet Resources for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Naveen Pemmaraju, Vikas Gupta, Michael A. Thompson, Andrew A. Lane
Sézary Syndrome: Clinical and Biological Aspects
Rebecca Kohnken, Stephanie Fabbro, Justin Hastings, Pierluigi Porcu, Anjali Mishra
CD30 and CD30-Targeted Therapies in Hodgkin Lymphoma and Other B cell Lymphomas
Geetika Bhatt, Kami Maddocks, Beth Christian
T-cell Lymphoma Epidemiology: the Known and Unknown
Anh Phan, Rachel Veldman, Mary Jo Lechowicz
Enteropathy-Associated T-Cell Lymphoma
Sarah Ondrejka, Deepa Jagadeesh
Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases
Bradley M. Haverkos, Zenggang Pan, Alejandro A. Gru, Aharon G. Freud, Rachel Rabinovitch, Meng Xu-Welliver, Brad Otto, Carlos Barrionuevo, Robert A. Baiocchi, Rosemary Rochford, Pierluigi Porcu
Acute Myeloid Leukemia: How Do We Measure Success?
Joshua P. Sasine, Gary J. Schiller
Definition of Unfit for Standard Acute Myeloid Leukemia Therapy
Heidi D. Klepin
Antibody-Based Treatment of Acute Myeloid Leukemia
Phillip M. Garfin, Eric J. Feldman